Pharmaceutical Technology Editors

GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.

EXCiPACT announces that DQS awarded Grace GmbH an EXCiPACT Certificate for its Worms, Germany excipient-manufacturing site.

The agency streamlines risk and mitigation information.

EvaluatePharma's report shows upward trends in R&D and drug approvals.

Lonza’s planned facility will be used to develop and manufacture viral gene therapies and virally modified cell therapies

The agency publishes guidance on the physical attributes of generic tablets and capsules.

MFG Tray names ChemTech International as its first Master Pharmaceutical Distributor.

A new SGS Life Science Services laboratory outside Paris is designed for bio/pharmaceutical quality control testing.

Kythera announces that it entered into a definitive agreement to be acquired by Allergan for $2.1 billion.

Stan Matthews, sales manager, processing division at MG America, spoke with Pharmaceutical Technology about trends and concerns in capsule production.

The Biotechnology Industry Organization announced a name change to the Biotechnology Innovation Organization, effective in early 2016.

Catalent’s Singapore facility is awarded GMP certification.

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Bayer Healthcare, Bristol-Myers Squibb, Sucampo Pharmaceuticals, Takeda Pharmaceuticals, and Horizon Pharma representatives join PhRMA board.

West Pharmaceutical began construction on its component manufacturing facility located in Waterford, Ireland.

At BIO 2015, CQDM and MaRS Innovation announced an investment in Encycle Therapeutics to research chemical properties needed to make peptide-like molecules orally bioavailable.

The agency creates initiative to stimulate pediatric drug development.

CPhI Worldwide announces five new categories for the 2015 CPhI Pharma Awards.

BPTF seeks changes in performance goals and fee payment schedule in GDUFA renegotiations.

A new GMP facility in Massachusetts will produce enzymes and other reagents for in-vitro diagnostics.

The exclusive manufacturing collaboration will establish production for adeno-associated virus gene-therapy treatments incorporating REGENXBIO’s NAV Technology.

The supplier will add Allied Laboratories and AR Brown to its list of global partners.

The product, marketed as Sirdupla in the United Kingdom, is the generic version of GSK’s beta agonist and corticosteroid combination treatment for asthma.

The agency issues draft guidance on the development of drugs to treat Duchenne muscular dystrophy.

A year after its merger with DSM Pharmaceutical Products, Patheon announces that it has filed an IPO.

Lyophilization Services of New England announces inspection approvals that will allow its Bedford, NH facility to begin manufacturing commercial drugs for US distribution.

The MF80 automated punch polisher offers increased polishing capacity per cycle.

At this year’s ACHEMA, Malvern brings to the exhibition floor, its expertise and tools for measuring particle size and shape, zeta potential, molecular weight, and rheological properties for the characterization of dispersed systems.

The design of the shovel means that less drive power is required compared with a standard shovel, thus resulting in substantial energy savings.

Talks will explore key trends and issues in the pharmaceutical space and address the “latest industry buzz.”